D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 69 Citations 19,982 213 World Ranking 647 National Ranking 312
Medicine D-index 77 Citations 24,134 261 World Ranking 11165 National Ranking 5964

Overview

What is he best known for?

The fields of study he is best known for:

  • Acquired immunodeficiency syndrome
  • Internal medicine
  • Virus

His main research concerns Virology, Acquired immunodeficiency syndrome, Immunology, Viral load and Internal medicine. His study in Virology is interdisciplinary in nature, drawing from both Efavirenz, Reverse transcriptase and Drug resistance. His Acquired immunodeficiency syndrome research incorporates themes from Clinical research, MEDLINE and Intensive care medicine.

His Immunology research is multidisciplinary, incorporating elements of Prospective cohort study, Pharmacotherapy, Cohort study and Antiretroviral therapy. His studies in Viral load integrate themes in fields like Viremia, Pain scale and Lentivirus. As part of one scientific family, David Katzenstein deals mainly with the area of Internal medicine, narrowing it down to issues related to the Gastroenterology, and often Chemotherapy.

His most cited work include:

  • Treatment for adult HIV infection : 2006 recommendations of the international AIDS society-USA panel (993 citations)
  • Antiretroviral Therapy for HIV Infection in 1998: Updated Recommendations of the International AIDS Society–USA Panel (956 citations)
  • Antiretroviral Therapy in Adults: Updated Recommendations of the International AIDS Society–USA Panel (956 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Virology, Immunology, Acquired immunodeficiency syndrome, Drug resistance and Internal medicine. His work is dedicated to discovering how Virology, Efavirenz are connected with Nevirapine and Reverse-transcriptase inhibitor and other disciplines. His work in Immunology addresses subjects such as Cohort, which are connected to disciplines such as Cohort study.

His Acquired immunodeficiency syndrome study focuses on Sida in particular. His research in Drug resistance intersects with topics in Mutation, HIV drug resistance, Resistance mutation and Genotyping, Genotype. David Katzenstein has included themes like Gastroenterology, Lamivudine, Oncology and Ritonavir in his Internal medicine study.

He most often published in these fields:

  • Virology (48.49%)
  • Immunology (34.11%)
  • Acquired immunodeficiency syndrome (26.42%)

What were the highlights of his more recent work (between 2013-2021)?

  • Drug resistance (23.75%)
  • Virology (48.49%)
  • Internal medicine (23.08%)

In recent papers he was focusing on the following fields of study:

David Katzenstein mostly deals with Drug resistance, Virology, Internal medicine, Viral load and HIV drug resistance. His Drug resistance study integrates concerns from other disciplines, such as Regimen, Acquired immunodeficiency syndrome, Immunology, Transmission and Genotyping. His Acquired immunodeficiency syndrome research includes themes of Cross-sectional study and Public health.

The study incorporates disciplines such as Mutation, Efavirenz, Resistance mutation, Genotype and Nevirapine in addition to Virology. He has researched Internal medicine in several fields, including Tuberculosis and Abacavir. His Viral load research includes elements of Viral suppression, Virological failure, Lopinavir, Ritonavir and Pediatrics.

Between 2013 and 2021, his most popular works were:

  • Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis. (172 citations)
  • Sustainable HIV Treatment in Africa through Viral Load-Informed Differentiated Care (115 citations)
  • HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing (58 citations)

In his most recent research, the most cited papers focused on:

  • Acquired immunodeficiency syndrome
  • Internal medicine
  • Virus

David Katzenstein focuses on Virology, Drug resistance, Viral load, Internal medicine and Regimen. He is involved in the study of Virology that focuses on Reverse-transcriptase inhibitor in particular. His studies deal with areas such as Nevirapine, Efavirenz and Transmission as well as Drug resistance.

His studies in Transmission integrate themes in fields like Acquired immunodeficiency syndrome, Sequence analysis, Public health and Random effects model. The various areas that David Katzenstein examines in his Viral load study include Intensive care medicine and Ritonavir. His Internal medicine study integrates concerns from other disciplines, such as Lamivudine and Pharmacology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Antiretroviral Therapy in Adults: Updated Recommendations of the International AIDS Society–USA Panel

Charles C. J. Carpenter;David A. Cooper;Margaret A. Fischl;Jose M. Gatell.
JAMA (2000)

1369 Citations

A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter

Scott M. Hammer;David A. Katzenstein;Michael D. Hughes;Holly Gundacker.
The New England Journal of Medicine (1996)

1281 Citations

Treatment for adult HIV infection : 2006 recommendations of the international AIDS society-USA panel

Scott M. Hammer;Michael S. Saag;Mauro Schechter;Julio S. G. Montaner.
JAMA (2006)

1109 Citations

Antiretroviral Treatment for Adult HIV Infection in 2002: Updated Recommendations of the International AIDS Society-USA Panel

Patrick G. Yeni;Scott M. Hammer;Charles C. J. Carpenter;David A. Cooper.
JAMA (2002)

965 Citations

Antiretroviral Therapy for HIV Infection in 1997: Updated Recommendations of the International AIDS Society—USA Panel

Charles C. J. Carpenter;Margaret A. Fischl;Scott M. Hammer;Martin S. Hirsch.
JAMA (1997)

962 Citations

Antiretroviral Therapy for HIV Infection in 1998: Updated Recommendations of the International AIDS Society–USA Panel

Charles C. J. Carpenter;Margaret A. Fischl;Scott M. Hammer;Martin S. Hirsch.
JAMA (1998)

956 Citations

Antiretroviral therapy for HIV infection in 1996 : Recommendations of an international panel

Charles C. J. Carpenter;Margaret A. Fischl;Scott M. Hammer;Martin S. Hirsch.
JAMA (1996)

769 Citations

Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

Patrick G. Yeni;Scott M. Hammer;Martin S. Hirsch;Michael S. Saag.
JAMA (2004)

718 Citations

Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.

C C Carpenter;M A Fischl;S M Hammer;M S Hirsch.
JAMA (1996)

625 Citations

The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter

David A. Katzenstein;Scott M. Hammer;Michael D. Hughes;Holly Gundacker.
The New England Journal of Medicine (1996)

546 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing David Katzenstein

Julio S. G. Montaner

Julio S. G. Montaner

University of British Columbia

Publications: 206

Robert S. Hogg

Robert S. Hogg

Simon Fraser University

Publications: 157

Andrew N. Phillips

Andrew N. Phillips

University College London

Publications: 108

Douglas D. Richman

Douglas D. Richman

University of California, San Diego

Publications: 106

Robert W. Shafer

Robert W. Shafer

Stanford University

Publications: 102

David A. Cooper

David A. Cooper

Pfizer (United States)

Publications: 100

Mark A. Wainberg

Mark A. Wainberg

McGill University

Publications: 94

Daniel R. Kuritzkes

Daniel R. Kuritzkes

Brigham and Women's Hospital

Publications: 94

Bruce D. Walker

Bruce D. Walker

Harvard University

Publications: 88

Joseph J. Eron

Joseph J. Eron

University of North Carolina at Chapel Hill

Publications: 88

Vincent Soriano

Vincent Soriano

Hospital Universitario La Paz

Publications: 87

Jens D. Lundgren

Jens D. Lundgren

Rigshospitalet

Publications: 80

Anne-Mieke Vandamme

Anne-Mieke Vandamme

Rega Institute for Medical Research

Publications: 77

Kenneth A. Freedberg

Kenneth A. Freedberg

Harvard University

Publications: 73

Kenneth H. Mayer

Kenneth H. Mayer

Fenway Health

Publications: 69

Benita Yip

Benita Yip

University of British Columbia

Publications: 69

Trending Scientists

Yuval Elovici

Yuval Elovici

Ben-Gurion University of the Negev

Lihua Tang

Lihua Tang

University of Auckland

Giorgio Zavarise

Giorgio Zavarise

University of Salento

Anantha Pradeep

Anantha Pradeep

Nielsen (United States)

Harold S. Johnston

Harold S. Johnston

University of California, Berkeley

Yuichi Shimakawa

Yuichi Shimakawa

Kyoto University

Jessica Gurevitch

Jessica Gurevitch

Stony Brook University

Frithjof C. Küpper

Frithjof C. Küpper

University of Aberdeen

Catherine Mével

Catherine Mével

Institut de Physique du Globe de Paris

Yifang Zhu

Yifang Zhu

University of California, Los Angeles

Paul Newman

Paul Newman

Goddard Space Flight Center

Robert D. McIntosh

Robert D. McIntosh

University of Edinburgh

Cheryl L. Willman

Cheryl L. Willman

University of New Mexico

Piotr Rutkowski

Piotr Rutkowski

Maria Sklodowska-Curie National Research Institute of Oncology

Louis B. Harrison

Louis B. Harrison

Moffitt Cancer Center

Eve C. Johnstone

Eve C. Johnstone

University of Edinburgh

Something went wrong. Please try again later.